Aarkstore - Grifols Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

1
Grifols Therapeutics, Inc. - Pharmaceuticals
Healthcare - Deals and Alliances Profile
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/26310/grifols-therapeutics-inc-pharmaceuticals-h
  ealthcare-deals-and-alliances-profile

2
Summary

• Grifols Therapeutics, Inc. (Grifols) formerly
  Talecris Biotherapeutics Inc, is a US-based
  publicly held pharmaceutical company. It engages
  in development, production, marketing and
  distribution of therapies for the treatment of
  chronic inflammatory demyelinating polyneuropathy
  (CIDP), primary immune deficiencies (PI), alpha-1
  antitrypsin deficiency, bleeding disorders,
  infectious diseases and severe trauma. The
  companys product portfolio comprises of gamunex,
  an immune globulin intravenous used to treat
  infectious or inflammatory diseases hypermunes,
  a hyperimmune globulin therapy used to treat
  patients with weak immune systems koate-DVI is
  an antihemophilic factor used for treatment of
  persons with hemophilia plasbumin, a protein
  produced by the liver used for the treatment of
  shock and blood loss due to trauma, burns, and
  surgery prolastin and thrombate III for the
  treatments of lungs and spontaneous clotting,
  respectively. Its geographic operations are
  spread across the US, Canada and Europe. The
  company received orphan drug designation from the
  US FDA for its aerosolized Alpha1-Proteinase
  Inhibitor (Human, A1PI), for the treatment of
  congenital alpha1-antitrypsin (AAT) deficiency.
  Grifols is headquartered in Research Triangle
  Park, the US.

3
Scope

• - Financial Deals - Analysis of the companys
  financial deals including Mergers and
  Acquisitions, Equity/Debt Offerings, Private
  Equity, Venture Financing and Partnerships.-
  Deals by Year - Chart and table displaying
  information encompassing the number of deals and
  value reported by the company by year, for a five
  year period.- Deals by Type - Chart and table
  depicting information including the number of
  deals and value reported by the company by type
  such as Mergers and Acquisitions, Equity/Debt
  Offering etc.- Deals by Region - Chart and table
  presenting information on the number of deals and
  value reported by the company by region, which
  includes North America, Europe, Asia Pacific, the
  Middle East and Africa and South and Central
  America.- Deals by Sub-sector - Chart and table
  showing information on the number of deals and
  value reported by the company, by sub-sector.-
  Major Deals - Information on the companys major
  financial deals. Each such deal has a brief
  summary, deal type, deal rationale and deal
  financials and target Companys (major public
  companies) key financial metrics and ratios.

4
Reasons to Buy

• Get detailed information on the companys
  financial deals that enable you to understand the
  companys expansion/divestiture and fund
  requirements- The profile enables you to analyze
  the companys financial deals by region, by year,
  by business segments and by type, for a five year
  period.Understand the companys business
  segments expansion / divestiture strategy- The
  profile presents deals from the companys core
  business segments perspective to help you
  understand its corporate strategy.Access
  elaborate information on the companys recent
  financial deals that enable you to understand the
  key deals which have shaped the company-
  Detailed information on major recent deals
  includes a summary of each deal, deal type, deal
  rationale, deal financials and Target Companys
  key financial metrics and ratios.Equip yourself
  with detailed information about the companys
  operations to identify potential customers and
  suppliers.- The profile analyzes the companys
  business structure, locations and subsidiaries,
  key executives and key competitors.

5
Table of Content

• Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals By Year, 2008 to YTD 2014
  4Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare Deals By Type, 2008 to YTD 2014
  5Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals By Region, 2008 to YTD 2014
  6Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals By Therapy Area, 2008 to YTD
  2014 7Grifols Therapeutics, Inc., Medical
  Devices Deals, 2008 to YTD 2014 8Grifols
  Therapeutics, Inc., Pharmaceuticals Healthcare,
  Deals Summary, 2008 to YTD 2014 9Grifols
  Therapeutics, Inc., Pharmaceuticals Healthcare,
  Deal Details 10Asset Purchase 10Talecris
  BioTherapeutics Acquires Three Plasma Centers
  From International BioResources 10Partnerships
  12Talecris Biotherapeutics Enters Into
  Co-Promotion Agreement With Novartis Vaccines And
  Diagnostics 12

6
List of Tables

• Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Key Facts 1Grifols Therapeutics,
  Inc., Pharmaceuticals Healthcare, Deals By
  Year, 2008 to YTD 2014 1Grifols Therapeutics,
  Inc., Pharmaceuticals Healthcare, Deals By
  Region, 2008 to YTD 2014 1Grifols Therapeutics,
  Inc., Pharmaceuticals Healthcare, Deals By
  Therapy Area, 2008 to YTD 2014 1Grifols
  Therapeutics, Inc., Pharmaceuticals Healthcare,
  Deals By Year, 2008 to YTD 2014 4Grifols
  Therapeutics, Inc., Pharmaceuticals Healthcare
  Deals By Type, 2008 to YTD 2014 5Grifols
  Therapeutics, Inc., Pharmaceuticals Healthcare,
  Deals By Region, 2008 to YTD 2014 6Grifols
  Therapeutics, Inc., Deals By Therapy Area, 2008
  to YTD 2014 7Grifols Therapeutics, Inc., Medical
  Devices Deals, 2008 to YTD 2014 8Grifols
  Therapeutics, Inc., Pharmaceuticals Healthcare,
  Deals Summary, 2008 to YTD 2014 9

7
List of Figures

• Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals by Type, 2008 to YTD 2014
  1Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals By Year, 2008 to YTD 2014
  4Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals by Type, 2008 to YTD 2014
  5Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals By Region, 2008 to YTD 2014
  6Grifols Therapeutics, Inc., Pharmaceuticals
  Healthcare, Deals By Therapy Area, 2008 to YTD
  2014 7Grifols Therapeutics, Inc., Medical
  Devices Deals, 2008 to YTD 2014 8

8
Related Reports

• Regis Healthcare Ltd Company Profile and SWOT
  Analysis
• Taisho Pharmaceutical Holdings Co., Ltd.
  Company Profile and SWOT Analysis
• Catalent, Inc. Company Profile and SWOT
  Analysis
• Immune Pharmaceuticals, Inc. (IMNP) -
  Pharmaceuticals Healthcare - Deals and
  Alliances Profile
• CEL-SCI Corporation (CVM) - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Grifols Therapeutics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Global Regenerative Medicine Market 2015-2019
• Japanese Encephalitis - Pipeline Review, H2 2014

9

• Grifols Therapeutics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Published Dec. 2014 25 Pages
• Grifols Therapeutics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile provides
  you comprehensive data and trend analysis of the
  companys Mergers and Acquisitions (MAs),
  partnerships and financings.
• Price

Format Price
PDF 250
Site Licence 500
Enterprise Wide Licence 750
10
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news